Abion Inc (203400)

Currency in KRW
3,685
-65(-1.73%)
Closed·
203400 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3,5803,825
52 wk Range
1,9116,136
Key Statistics
Bid/Ask
3,685.00 / 3,690.00
Prev. Close
3,750
Open
3,770
Day's Range
3,580-3,825
52 wk Range
1,911-6,136
Volume
2.03M
Average Volume (3m)
2.38M
1-Year Change
13.0428%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
203400 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Biotechnology industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral

Abion Company Profile

ABION Inc. operates as a pharmaceutical biotech Company in South Korea and internationally. The company develops anticancer therapeutic drugs, such as ABN401, a tyrosine kinase inhibitor that is in Phase II clinical trials for treating non-small cell lung cancer, as well as in Phase I clinical trial for breast cancer; ABN501, a human monoclonal antibody that targets claudin 3 for treating solid cancers; ABN201, an antibody cytokine fusion protein to treat solid cancers; and ABN101, a dry powder inhaler as a prophylactic treatment for various respiratory viruses. It is also developing ABN701 for SEBI infectious diseases; and ABN 901, ABN 902, and ABN 903 for infectious diseases related to biological disasters. Abion Inc. was founded in 2007 and is based in Seoul, South Korea.

Compare 203400 to Peers and Sector

Metrics to compare
203400
Peers
Sector
Relationship
P/E Ratio
−11.8x−11.7x−0.6x
PEG Ratio
−0.23−0.330.00
Price/Book
35.4x3.7x2.6x
Price / LTM Sales
321.9x16.7x3.4x
Upside (Analyst Target)
-251.3%44.4%
Fair Value Upside
Unlock2.6%6.1%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Oct 31, 2025
EPS / Forecast
-182.00 / --
Revenue / Forecast
162.04M / --
EPS Revisions
Last 90 days

Abion (203400) Income Statement & Profits

People Also Watch

26,150
105840
-3.33%
67,000
103590
+3.40%
73,900.00
389470
-7.28%
74,400
323280
+3.91%
113,000.00
475830
-0.44%

FAQ

What Is the Abion (203400) Share Price Today?

The live Abion share price today is 3,685

What Stock Exchange Does Abion (203400) Trade On?

Abion is listed and trades on the KOSDAQ.

What Is the Ticker (Stock Symbol) for Abion?

The stock symbol (also called a 'ticker') for Abion is "203400."

What Is the Current Abion Market Cap?

As of today, Abion market capitalisation is 332.02B.

What Is Abion's (203400) Earnings Per Share (TTM)?

The Abion EPS is currently -553.66 (Trailing Twelve Months).

Is 203400 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Abion moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Abion Stock Split?

Abion has split 1 times. (See the 203400 stock split history page for full effective split date and price information.)

What is the current trading status of Abion (203400)?

As of 30 Jan 2026, Abion (203400) is trading at a price of 3,685, with a previous close of 3,750. The stock has fluctuated within a day range of 3,580 to 3,825, while its 52-week range spans from 1,911 to 6,136.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.